SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-054153
Filing Date
2024-04-29
Accepted
2024-04-29 17:03:40
Documents
14
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2412915d1_10ka.htm   iXBRL 10-K/A 278927
2 EXHIBIT 31.1 tm2412915d1_ex31-1.htm EX-31.1 12554
  Complete submission text file 0001104659-24-054153.txt   538871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20231231.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20231231_lab.xml EX-101.LAB 35431
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20231231_pre.xml EX-101.PRE 23129
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2412915d1_10ka_htm.xml XML 6095
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35737 | Film No.: 24892378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)